Both in Biotechnology
Ginkgo Bioworks Holdings vs Cullinan Therapeutics
Over the past year DNA returned +4.6% and CGEM returned +83.3%; their daily moves had a correlation of 0.25.
DNA +4.6% CGEM +83.3%Growth of $1, one year, split-adjusted
| Metric | DNA | CGEM |
|---|---|---|
| Price | $13.32 | $15.56 |
| Market cap | $897.0M | $1.00B |
| Today | +18.19% | +4.85% |
| 1 month | +11.4% | +2.2% |
| 6 months | +77.6% | +21.1% |
| Year to date | +60.3% | +50.3% |
| 1 year | −0.5% | +93.1% |
| Revenue growth (YoY) | −48.5% | — |
| Gross margin | 91.5% | — |
| Net margin | −231.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 8.0× | — |
| Net cash | $302.2M | $334.5M |
| Dividend yield | — | — |
| Volatility (60d) | 123.6% | 75.3% |
| Short % of float | 18.4% | 14.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).